Reviews Raplon


No reviews yet.

Raplon Drug Description


DRUG DESCRIPTION
RAPLONTM (rapacuronium bromide) for Injection
THIS DRUG SHOULD BE ADMINISTERED BY ADEQUATELY TRAINED INDIVIDUALS FAMILIAR WITH ITS ACTIONS, CHARACTERISTICS AND HAZARDS.

RAPLONTM (rapacuronium bromide) for injection is a nondepolarizing neuromuscular blocking agent its chemical name is 1-[(2b , 3a , 5a , 16b , 17b )-3-(Acetyloxy)-17-(1-oxopropoxy)-2-(1-piperidiny)androstan-16-yl]-1-(2-propenyl) piperidinium bromide. The chemical formula of the bromide salt is C37H81BrN2O4 with a molecular weight of 677.78.
RAPLOMTM is a synthetic steroid molecule with a mono-quaternary structure in the form of a bromide salt. This chemical structure has a basic steroid framework similar to other neuromuscular blocking agents like vecuronium, pancuronium, rocuronium, and pipecuronium. Rapacuronium bromide is distinguished as being a propenyl bromide ammonium salt with a 17-hydroxy propionate carboxyester that has the same basic steroid backbone as the rest of the family of steroid neuromuscular blockers.
RAPLONÒ is supplied as a sterile, nonpyrogenic lyophilized cake in 5-mL and 10-mL vials. Each 5-mL vial contains 100 mg of rapacuronium bromide base. 35.8 mg citric acid anhydrous. 7.5 mg of sodium phosphate dibasic anhydrous. 137.5 mg of mannitol, and sodium hydroxide and/or phosphoric acid to buffer and adjust the pH. When the 5-mL vial is reconstituted to a volume of 5 mL with sterile water for injection or bacteriostatic water for injection, an isotonic preparation for intravenous injection is obtained at a pH of 4.0 with a concentration of 20 mg of rapacuronium bromide based per mL. Each10-mL vial contains 200 mg of rapacuronium bromide based, 71.5 mg of citric acid an hydroxide and/or phosphoric acide to buffer and adjust the pH. When the 10-mL vial is reconstituted to a volume of 10 mL with sterile water for injection or bacteriostatic water for injection, an isotonic preparation for intravenous injection is obtained at a pH of 4.0 with a concentration of 20 mg of rapacuronium bromide base per mL.Last reviewed on RxList: 12/8/2004




Raplon Drug Description


DRUG DESCRIPTION
RAPLONTM (rapacuronium bromide) for Injection
THIS DRUG SHOULD BE ADMINISTERED BY ADEQUATELY TRAINED INDIVIDUALS FAMILIAR WITH ITS ACTIONS, CHARACTERISTICS AND HAZARDS.

RAPLONTM (rapacuronium bromide) for injection is a nondepolarizing neuromuscular blocking agent its chemical name is 1-[(2b , 3a , 5a , 16b , 17b )-3-(Acetyloxy)-17-(1-oxopropoxy)-2-(1-piperidiny)androstan-16-yl]-1-(2-propenyl) piperidinium bromide. The chemical formula of the bromide salt is C37H81BrN2O4 with a molecular weight of 677.78.
RAPLOMTM is a synthetic steroid molecule with a mono-quaternary structure in the form of a bromide salt. This chemical structure has a basic steroid framework similar to other neuromuscular blocking agents like vecuronium, pancuronium, rocuronium, and pipecuronium. Rapacuronium bromide is distinguished as being a propenyl bromide ammonium salt with a 17-hydroxy propionate carboxyester that has the same basic steroid backbone as the rest of the family of steroid neuromuscular blockers.
RAPLONÒ is supplied as a sterile, nonpyrogenic lyophilized cake in 5-mL and 10-mL vials. Each 5-mL vial contains 100 mg of rapacuronium bromide base. 35.8 mg citric acid anhydrous. 7.5 mg of sodium phosphate dibasic anhydrous. 137.5 mg of mannitol, and sodium hydroxide and/or phosphoric acid to buffer and adjust the pH. When the 5-mL vial is reconstituted to a volume of 5 mL with sterile water for injection or bacteriostatic water for injection, an isotonic preparation for intravenous injection is obtained at a pH of 4.0 with a concentration of 20 mg of rapacuronium bromide based per mL. Each10-mL vial contains 200 mg of rapacuronium bromide based, 71.5 mg of citric acid an hydroxide and/or phosphoric acide to buffer and adjust the pH. When the 10-mL vial is reconstituted to a volume of 10 mL with sterile water for injection or bacteriostatic water for injection, an isotonic preparation for intravenous injection is obtained at a pH of 4.0 with a concentration of 20 mg of rapacuronium bromide base per mL.Last reviewed on RxList: 12/8/2004




Raplon Drug Description


DRUG DESCRIPTION
RAPLONTM (rapacuronium bromide) for Injection
THIS DRUG SHOULD BE ADMINISTERED BY ADEQUATELY TRAINED INDIVIDUALS FAMILIAR WITH ITS ACTIONS, CHARACTERISTICS AND HAZARDS.

RAPLONTM (rapacuronium bromide) for injection is a nondepolarizing neuromuscular blocking agent its chemical name is 1-[(2b , 3a , 5a , 16b , 17b )-3-(Acetyloxy)-17-(1-oxopropoxy)-2-(1-piperidiny)androstan-16-yl]-1-(2-propenyl) piperidinium bromide. The chemical formula of the bromide salt is C37H81BrN2O4 with a molecular weight of 677.78.
RAPLOMTM is a synthetic steroid molecule with a mono-quaternary structure in the form of a bromide salt. This chemical structure has a basic steroid framework similar to other neuromuscular blocking agents like vecuronium, pancuronium, rocuronium, and pipecuronium. Rapacuronium bromide is distinguished as being a propenyl bromide ammonium salt with a 17-hydroxy propionate carboxyester that has the same basic steroid backbone as the rest of the family of steroid neuromuscular blockers.
RAPLONÒ is supplied as a sterile, nonpyrogenic lyophilized cake in 5-mL and 10-mL vials. Each 5-mL vial contains 100 mg of rapacuronium bromide base. 35.8 mg citric acid anhydrous. 7.5 mg of sodium phosphate dibasic anhydrous. 137.5 mg of mannitol, and sodium hydroxide and/or phosphoric acid to buffer and adjust the pH. When the 5-mL vial is reconstituted to a volume of 5 mL with sterile water for injection or bacteriostatic water for injection, an isotonic preparation for intravenous injection is obtained at a pH of 4.0 with a concentration of 20 mg of rapacuronium bromide based per mL. Each10-mL vial contains 200 mg of rapacuronium bromide based, 71.5 mg of citric acid an hydroxide and/or phosphoric acide to buffer and adjust the pH. When the 10-mL vial is reconstituted to a volume of 10 mL with sterile water for injection or bacteriostatic water for injection, an isotonic preparation for intravenous injection is obtained at a pH of 4.0 with a concentration of 20 mg of rapacuronium bromide base per mL.Last reviewed on RxList: 12/8/2004




Raplon Drug Description


DRUG DESCRIPTION
RAPLONTM (rapacuronium bromide) for Injection
THIS DRUG SHOULD BE ADMINISTERED BY ADEQUATELY TRAINED INDIVIDUALS FAMILIAR WITH ITS ACTIONS, CHARACTERISTICS AND HAZARDS.

RAPLONTM (rapacuronium bromide) for injection is a nondepolarizing neuromuscular blocking agent its chemical name is 1-[(2b , 3a , 5a , 16b , 17b )-3-(Acetyloxy)-17-(1-oxopropoxy)-2-(1-piperidiny)androstan-16-yl]-1-(2-propenyl) piperidinium bromide. The chemical formula of the bromide salt is C37H81BrN2O4 with a molecular weight of 677.78.
RAPLOMTM is a synthetic steroid molecule with a mono-quaternary structure in the form of a bromide salt. This chemical structure has a basic steroid framework similar to other neuromuscular blocking agents like vecuronium, pancuronium, rocuronium, and pipecuronium. Rapacuronium bromide is distinguished as being a propenyl bromide ammonium salt with a 17-hydroxy propionate carboxyester that has the same basic steroid backbone as the rest of the family of steroid neuromuscular blockers.
RAPLONÒ is supplied as a sterile, nonpyrogenic lyophilized cake in 5-mL and 10-mL vials. Each 5-mL vial contains 100 mg of rapacuronium bromide base. 35.8 mg citric acid anhydrous. 7.5 mg of sodium phosphate dibasic anhydrous. 137.5 mg of mannitol, and sodium hydroxide and/or phosphoric acid to buffer and adjust the pH. When the 5-mL vial is reconstituted to a volume of 5 mL with sterile water for injection or bacteriostatic water for injection, an isotonic preparation for intravenous injection is obtained at a pH of 4.0 with a concentration of 20 mg of rapacuronium bromide based per mL. Each10-mL vial contains 200 mg of rapacuronium bromide based, 71.5 mg of citric acid an hydroxide and/or phosphoric acide to buffer and adjust the pH. When the 10-mL vial is reconstituted to a volume of 10 mL with sterile water for injection or bacteriostatic water for injection, an isotonic preparation for intravenous injection is obtained at a pH of 4.0 with a concentration of 20 mg of rapacuronium bromide base per mL.Last reviewed on RxList: 12/8/2004




Raplon Drug Description


DRUG DESCRIPTION
RAPLONTM (rapacuronium bromide) for Injection
THIS DRUG SHOULD BE ADMINISTERED BY ADEQUATELY TRAINED INDIVIDUALS FAMILIAR WITH ITS ACTIONS, CHARACTERISTICS AND HAZARDS.

RAPLONTM (rapacuronium bromide) for injection is a nondepolarizing neuromuscular blocking agent its chemical name is 1-[(2b , 3a , 5a , 16b , 17b )-3-(Acetyloxy)-17-(1-oxopropoxy)-2-(1-piperidiny)androstan-16-yl]-1-(2-propenyl) piperidinium bromide. The chemical formula of the bromide salt is C37H81BrN2O4 with a molecular weight of 677.78.
RAPLOMTM is a synthetic steroid molecule with a mono-quaternary structure in the form of a bromide salt. This chemical structure has a basic steroid framework similar to other neuromuscular blocking agents like vecuronium, pancuronium, rocuronium, and pipecuronium. Rapacuronium bromide is distinguished as being a propenyl bromide ammonium salt with a 17-hydroxy propionate carboxyester that has the same basic steroid backbone as the rest of the family of steroid neuromuscular blockers.
RAPLONÒ is supplied as a sterile, nonpyrogenic lyophilized cake in 5-mL and 10-mL vials. Each 5-mL vial contains 100 mg of rapacuronium bromide base. 35.8 mg citric acid anhydrous. 7.5 mg of sodium phosphate dibasic anhydrous. 137.5 mg of mannitol, and sodium hydroxide and/or phosphoric acid to buffer and adjust the pH. When the 5-mL vial is reconstituted to a volume of 5 mL with sterile water for injection or bacteriostatic water for injection, an isotonic preparation for intravenous injection is obtained at a pH of 4.0 with a concentration of 20 mg of rapacuronium bromide based per mL. Each10-mL vial contains 200 mg of rapacuronium bromide based, 71.5 mg of citric acid an hydroxide and/or phosphoric acide to buffer and adjust the pH. When the 10-mL vial is reconstituted to a volume of 10 mL with sterile water for injection or bacteriostatic water for injection, an isotonic preparation for intravenous injection is obtained at a pH of 4.0 with a concentration of 20 mg of rapacuronium bromide base per mL.Last reviewed on RxList: 12/8/2004





Other reviews about Raplon on wordpress

Organon's Raplon Debacle: Of Lowenstein Sandler's Most Recent Inconsistent Arguments in an August 25, 2008 Memorandum of Law
  by condor
You'll recall that another well-regarded, largely successful litigation law firm was ultimately vexed by asserting, in an earlier reply memorandum of law, in this very case, that […]


Relator in Organon Raplon Qui Tam Fraud Matter Fires Back
  by condor
Over the Christmas holidays, lawyers for Dr. Feldstein -- the whistle-blower in the Organon Raplon Qui Tam/False Claims Act suit -- answered Schering's latest motion seeking dismissal, […]



Other reviews about Raplon on web:

Learn about the prescription medication Raplon (Rapacuronium), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Raplon (Rapacuronium) Drug Information: Uses, Side Effects, Drug ...


Rapacuronium (Raplon) is a rapidly acting, non-depolarizing neuromuscular blocker formerly used in modern anaesthesia, to aid and enable endotracheal intubation, which is often ... Rapacuronium - Wikipedia, the free encyclopedia


Raplon,Pennsylvania Pharmaceutical Drug Lawyers, Prescription Medication Dangers, Side Effects, Manufacturer Negligence, Vioxx, Heart Attacks, Suicide, Anti Depressants, PA Injury ... Raplon: Pennsylvania Pharmaceutical Drug Lawyers, Prescription ...


Kansas City Raplon Attorneys – Jackson County Pharmaceutical Litigation Lawyers, Dangerous Drugs, Anesthetic, Bronchospasm, Skeletal Muscle Relaxation During Surgical Procedures ... Kansas City Raplon Attorneys – Jackson County Pharmaceutical ...


Raplon shown to adverse side effects. Raplon was linked with a condition known as bronchiospasm About Raplon: Dangers, bronchiospasm. Legal Claims.


Raplon prescribed as a muscle relaxant before surgical procedures. The FDA Approved Uses, Side Effects, Warnings, Alerts, FAQs here. Prescribed Raplon: FDA Approved Uses, Side Effects, Warnings ...


Raplon Dosages & Strengths; Strength Format Route Strength Class; Raplon 100 mg: powder for injection: intravenous: 1.0 each: OTC: Raplon 200 mg: powder for injection Raplon Drug Information : Medications.com


Raplon Information, Learn About Raplon, Raplon Forums, How to Take Raplon, Raplon Side Effects, Raplon Interactions, Discussion Threads, Medication Warnings, Raplon Overdose ... Raplon - The People's Medicine Community


Raplon is an anesthetic used to relax skeletal muscles during surgery. It was approved for use by the FDA in August of 1999. Raplon is being voluntarily pulled off the market ... Foy & Associates, P.C. • Atlanta Personal Injury Lawyers ...


Drug information and side-effects for Raplon ... Useful Websites. Medical Tourism Compare and save on surgery Global Translations Raplon - Drug information from MediLexicon





Featured Reviews

Reviews Methohexital Sodium for Injection

Brevital Sodium Drug Description BREVITAL® SODIUM (methohexital sodium) for Injection, USP WARNING Brevital should be used only in hospital or ambulatory care settings that provide for continuous monitoring of respiratory...
Read More  |  Review This
Reviews Glyburide Tablets

DiaBeta Drug Description Diaβeta® (glyburide) Tablets USP 1.25, 2.5 and 5 mg DRUG DESCRIPTION What are the possible side effects of glyburide (DiaBeta, Glynase PresTab, Micronase)? Stop taking glyburide and seek emergency...
Read More  |  Review This
Reviews Ziana Gel

Ziana Gel Drug Description ZIANA Gel (clindamycin phosphate 1.2% and tretinoin 0.025%) DRUG DESCRIPTION What are the possible side effects of clindamycin and tretinoin topical (Ziana)? Get emergency medical help if you have any...
Read More  |  Review This
Reviews Prednisolone Sodium Phosphate

Orapred ODT Drug Description Orapred ODT® (prednisolone sodium phosphate) Orally Disintegrating Tablets DRUG DESCRIPTION What are the possible side effects of prednisolone? Get emergency medical help if you have any of these...
Read More  |  Review This
Reviews Pandel

Pandel Drug Description Pandel® (hydrocortisone probutate cream) Cream, 0.1% For Dermatologic Use Only Not for Ophthalmic Use DRUG DESCRIPTION Pandel Cream contains hydrocortisone probutate, a synthetic adrenocorticosteroid, ...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....